Rahul Banerjee: Can Microbiome Predict Responses After ide-cel CAR-T in Myeloma?
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared Blood Journals Portfolio‘s post on X, adding:
“Fascinating Blood Advances work by MDACC and Moffitt: Can stool microbiome predict responses and AEs after ide-cel CAR-T in myeloma?
Krina Patel my apologies for condensing excellent paper into a meme, but looks like E. faecalis dominance was the villain we now know about!”
Blood Journals Portfolio shared a post on X, about recent article by Satabdi Saha et al. published in Blood Advances:
“Bacterial diversity decreased after ide-cel infusion, and bacterial composition was associated with ide-cel response and toxicities.”
Title: Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
Authors: Satabdi Saha, Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel, Mahmoud Gaballa, Sheeba K. Thomas, Hans C. Lee, Chia-Chi Chang, Reetakshi Arora, Meghan Menges, Salvatore Corallo, Marco L. Davila, Frederick L. Locke, Mark R. Tanner, Sattva S. Neelapu, Elizabeth J. Shpall, Christopher R. Flowers, Robert Z. Orlowski, Robert R. Jenq, Michael D. Jain, Christine Peterson, Doris K. Hansen, Neeraj Y. Saini, Krina K. Patel
Read the Full Article on Blood Advances
More posts featuring Rahul Banerjee.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023